Towards the lowest efficacious dose (ToLEDo): results of a multicenter non‐inferiority randomized open‐label controlled trial assessing Tocilizumab or Abatacept injection spacing in rheumatoid arthritis in remission
Author / Organization: Joanna Kedra, Philippe Dieudé, Caroline Giboin, Hubert Marotte, Carine Salliot, Thierry Schaeverbeke, Aleth Perdriger, Martin Soubrier, Jacques Morel, Arnaud Constantin, Emmanuelle Dernis, Valérie Royant, Jean‐hugues Salmon, Thao Pham, Jacques‐eric Gottenberg, Edouard Pertuiset, Maxime Dougados, Valérie Devauchelle-Pensec, Philippe Gaudin, Grégoire Cormier, Philippe Goupille, Xavier Mariette, Francis Berenbaum, Didier Alcaix, Sid‐ahmed Rouidi, Jean‐Marie Berthelot, Agnès Monnier, Christine Piroth, Frédéric Lioté, Vincent Goëb, Cécile Gaujoux-Viala, Isabelle Chary-Valckenaere, David Hajage, Florence Tubach, Bruno Fautrel
| File Format | PDF (Portable Document Format) |
|---|---|
| Publication Year | 2024 |
| Source Host |
HAL Open Science
(hal.science)
|
| License / Terms | Open Access / Creative Commons |
Ready for Immediate Access
Your selected document is ready for instant access with zero mandatory waiting period.